NYSE$HR
Healthcare Realty Trust Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Announced results for the three and six months ended June 30, 2021.
Healthcare Trust of America reported a net income of $0.17 per diluted share. FFO was $0.44 per diluted share, a 10.0% increase compared to Q2 2020. Normalized FFO was $0.44 per diluted share, up 4.8% from Q2 2020.
- Reported net income attributable to common stockholders of $0.17 per diluted share.
- Reported Funds From Operations (“FFO”), as defined by NAREIT, of $0.44 per diluted share, an increase of 10.0% compared to Q2 2020.
- Reported Normalized FFO of $0.44 per diluted share, an increase of 4.8% compared to Q2 2020.
- Reported Same-Property Cash Net Operating Income (“NOI”) growth of 2.1% compared to Q2 2020.
Headline financials
Revenue & EPS history
Healthcare Realty · Revenue · Quarterly
$189M
Revenue by segment
Healthcare Realty · $4.26M total across 1 segment · Q3 2023
- Interest Income$4.26M+26.7%100.0%
Forward guidance
HTA updates its 2021 guidance to range as follows: Net income attributable to common stockholders per share $0.40-$0.44, Same-Property Cash NOI 2.0%-2.5%, FFO per share, as defined by NAREIT $1.70-$1.77, Normalized FFO per share $1.74-$1.78.
Tailwinds
- $375 - $600 million of investments at an average 5.5% to 6.0% yield
- $70 - $125 million of dispositions at a 5.0% to 6.5% yield
- general and administrative costs of $43 - $46 million
- average fully diluted shares of between 224 and 226 million fully diluted shares of common stock outstanding, with proceeds from equity previously raised on a forward basis being utilized to fund acquisitions as they close
- developments being substantially completed as planned
Headwinds
- The lower end of the range assumes settlement of forward equity agreements without deployment of cash proceeds for investments.
- HTA expects leverage, measured as (i) debt less cash and cash equivalents to total capitalization, and (ii) measured as debt less cash and cash equivalents to Adjusted EBITDAre to range between 5.5x and 6.0x throughout the year.
- HTA’s 2021 guidance is based on a number of assumptions that are subject to change and many of which are beyond HTA’s control.
- HTA’s guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any.
- There can be no assurance that HTA will achieve these results.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-0.6%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.2%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+5.8%
Q3 2022
Best reaction
-10.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +8.2% | +6.6% | |
| Q4 2025 | +2.7% | +3.1% | +2.8% | |
| Q3 2025 | -0.6% | +1.0% | +2.6% | |
| Q1 2025 | -4.4% | -4.3% | -8.7% | |
| Q4 2024 | -1.3% | -1.0% | -2.2% | |
| Q3 2024 | -5.3% | -5.1% | +1.0% | |
| Q2 2024 | -0.3% | +0.8% | +1.7% | |
| Q1 2024 | +2.1% | +2.5% | +10.2% | |
| Q4 2023 | -10.1% | -8.8% | -17.8% | |
| Q3 2023 | +1.1% | -1.1% | +5.1% | |
| Q2 2023 | -6.0% | -8.5% | -15.3% | |
| Q1 2023 | -1.5% | +0.6% | -1.4% | |
| Q4 2022 | +0.7% | -4.0% | -5.9% | |
| Q3 2022 | +5.8% | +0.4% | +0.6% | |
| Q2 2022 | +3.6% | +3.9% | -4.0% | |
| Q1 2022 | -0.2% | -2.4% | -9.8% | |
| Q4 2021 | -8.8% | -4.5% | -5.2% | |
| Q3 2021 | +1.2% | +1.8% | -0.9% | |
| Q2 2021 | -2.6% | -0.5% | -2.3% | |
| Q1 2021 | +2.5% | +0.8% | -1.4% | |
| Q4 2020 | +0.4% | +0.7% | -0.3% | |
| Q3 2020 | +4.6% | +7.3% | +3.8% | |
| Q2 2020 | +1.6% | -1.6% | +2.8% | |
| Q1 2020 | +4.0% | +9.2% | +10.0% | |
| Q4 2019 | +1.2% | +1.8% | -6.3% | |
| Q3 2019 | -6.6% | -7.4% | -4.6% | |
| Q2 2019 | -1.1% | -0.6% | +2.2% | |
| Q1 2019 | -0.4% | +0.3% | +4.4% | |
| Q4 2018 | +2.0% | +2.7% | +0.4% | |
| Q3 2018 | -1.3% | +2.5% | +11.3% | |
| Q2 2018 | +2.7% | +4.1% | +4.0% | |
| Q1 2018 | +1.8% | +1.2% | +0.4% | |
| Q4 2017 | -2.1% | -0.8% | -1.5% | |
| Q3 2017 | +0.4% | +1.3% | +2.9% | |
| Q2 2017 | +0.3% | -0.3% | +0.5% | |
| Q1 2017 | -1.5% | +1.0% | +7.3% | |
| Q4 2016 | +2.7% | +2.8% | +3.4% | |
| Q3 2016 | -3.6% | -1.4% | -5.5% | |
| Q2 2016 | +0.3% | -0.6% | -0.5% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | -0.7% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | -1.2% | — | — | |
| Q1 2014 | -1.6% | — | — | |
| Q4 2013 | +1.1% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | -3.9% | — | — | |
| Q1 2013 | +0.7% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | -0.9% | — | — | |
| Q1 2012 | -4.0% | — | — | |
| Q1 2011 | -4.0% | — | — | |
| Q4 2009 | +1.1% | — | — | |
| Q4 2011 | +1.1% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q4 2010 | +3.4% | — | — | |
| Q2 2011 | +3.4% | — | — | |
| Q3 2010 | -6.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q1 2010 | -6.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro